Introduction

In light of advancements in healthcare and the discovery of novel therapies, the overall health of societies and global life expectancy have seen marked improvements. However, the challenge of effectively treating chronic conditions, including hereditary diseases and cancers, remains unresolved in modern medicine. Recent progress in medical science has led to the emergence of regenerative medicine, encompassing gene therapy, cell therapy, and tissue engineering. This field made viable through the collaboration of experts in basic and clinical sciences, has yielded new treatments for previously fatal and incurable diseases. These developments have unveiled the potential for tissue production and repair, organ regeneration, and treating hereditary and cancerous diseases.

The significant interest shown by researchers and scientists globally, along with substantial investments made by advanced nations, underscores the profound impact of regenerative medicine in disease treatment and its projected influence at national and international levels. Despite the comparatively modest investment, Iran has made impressive strides in cell and gene therapy and currently ranks 14th globally for science production in the Scopus database. The remarkable expertise of Iranian researchers in regenerative medicine signifies the country's possession of specialized human resources for producing cutting-edge knowledge in this field.

Perspectives

1. The advancement and implementation of cell and gene therapy to enhance societal health.

2. The scientific and executive enhancement of human capital to translate ideas into products and technologies, enabling entry into the knowledge-based market and treatment of incurable diseases.

3. The establishment and expansion of local infrastructures essential for research and technology development to showcase and compete with accomplishments on national and international platforms.

4. The engagement of benefactors, investors, and policymakers in advancing science and technology in cell and gene therapy and broadening scientific frontiers.

5. Fostering a culture of participation and accountability among researchers, technologists, and physicians.

Objectives

1. To advance and apply human knowledge in cell and gene therapy.

2. To conduct foundational and clinical research in cell and gene therapy.

3. To curate, catalog, and classify documents, articles, and relevant materials and to publish them.

4. To provide training for individuals pursuing cell and gene therapy research careers.

5. To recruit, motivate, and engage researchers, physicians, and students.

6. To garner attention and collaboration from pertinent research and administrative entities within the country.

7. To engage in scientific cooperation with research and educational institutions in other countries and international organizations by the laws and regulations of Iran.

Strategies

1. Establishing and advancing the essential infrastructure to facilitate the development of knowledge and technologies in cell and gene therapy.

2. Support research in knowledge generation and technology development, particularly in priority areas.

3. Attracting and empowering the requisite human resources in research, technology, and services within this field.

4. Promotion, cultural assimilation, and dissemination of information are integral to effectively harnessing the scientific community's benefit from the advancements and progress in this domain.

5. Actively and effectively engaging with other nations.

6. Developing products based on cell and gene therapy to treat currently incurable diseases.

7. Encouraging the involvement of non-governmental sectors and charitable organizations in advancing research and technologies in this field.

8. Generating and publishing articles in reputable journals to establish scientific credibility.